SINT: Sintx Technologies Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand sintx.com (SINT)

The P/E ratio adjusted for EPS growth reflects market expectations, with the indicator currently standing at 0.00. Sintx Technologies (SINT) aims to displace metals in prosthetics by implementing ultra-strong ceramics. The brand's high authority among surgeons is supported by the unique antibacterial properties of its materials. Simultaneously, the company adheres to environmental standards, focusing on energy efficiency and the recycling of production waste.

Sintx Technologies (SINT) - PEG Multiple from 07/04/2022 to 11/10/2026
Manufactured products of Sintx Technologies, Inc.

The PEG ratio compares the P/E multiple with earnings growth rates to determine the fairness of an asset's current valuation. For Sintx Technologies (SINT), this metric is critical due to the high cost of silicon nitride production and a reliance on defense contracts. By analyzing the P/E ratio relative to projected growth on GURU.Markets, an investor can assess the balance between implant risks and expansion potential. Values below one signal that the business is undervalued. This indicator serves as a filter to separate speculation from fundamental growth.

Competing companies

Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate iLet Bionic Pancreas|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|AxoGen Inc (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Corp OFIX|PEG Multiple BVS (Bioventus Inc.)|PEG Multiple OrthoPediatrics Corp KIDS|TMCI - Price/Earnings to Growth Ratio|SRTA: Price/Earnings to Growth Ratio|CARL (Carlsmed Corp) - Price/Earnings to Growth Multiple|RxSight Ophthalmic - Growth-Adjusted Payback Ratio|CLPT (ClearPoint Neuro Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate stereotaxis.com STXS|Price/Earnings to Growth Ratio Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Price to Net Income Growth Ratio|Orchestra BioMed - Price/Earnings to Growth Multiple|PEG Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Jin Medical International ZJYL|vivani.com (VANI) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio XTNT (Xtant Medical)|Price/Earnings to Growth Ratio NeuroOne Corp|Price/Earnings to Growth Multiple Modular Med (MODD)|PEG Multiple MYO|COCH - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Vivos Therapeutics, Inc. VVOS|NVNO: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|Lifeward Ltd. - Company Value to Earnings Growth Ratio|autonomix.com (AMIX) - Price/Earnings to Growth Ratio|IVF - Growth-Adjusted Market Cap to Net Income|BBLG (Bone Biologics Corp) - PEG Multiple|Axonics Inc. (AXNX) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Biolase, Inc. (BIOL)|dynatronics.com - Growth-Adjusted P/E Ratio|Paragon 28 - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio INVO (INVO Bioscience Inc.)